SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eris Lifesciences concludes acquisition of India brand business of Strides Shasun

05 Dec 2017 Evaluate

Eris Lifesciences has achieved closure for the acquisition of India brand business of Strides Shasun. In November, Eris Lifesciences had entered into definitive agreements with Strides Shasun for acquisition of Strides’ branded generics business in India for an aggregate cash consideration of Rs 500 crore. In terms of the agreement, Eris would acquire the marketing and distribution rights for the said portfolio of products in India while Strides will retain the global rights for these products.

Eris Lifesciences is engaged in manufacturing, marketing and selling of branded generics within the chronic and acute categories of the Indian Pharmaceutical Market.



Eris Lifesciences Share Price

1386.75 3.10 (0.22%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×